Definium Therapeutics, Inc. (DFTX)
Definium Therapeutics, Inc. (DFTX)
For the quarter ending 2026-03-31, DFTX has $401,293K in assets. $122,444K in debts. $262,518K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 262,518 | 257,837 | ||
| Short-term investments | 110,904 | 153,756 | ||
| Prepaid and other current assets | 7,141 | 7,727 | ||
| Total current assets | 380,563 | 419,320 | ||
| Goodwill | 19,918 | 19,918 | ||
| Other non-current assets | 812 | 862 | ||
| Total assets | 401,293 | 440,100 | ||
| Accounts payable | 7,127 | 5,347 | ||
| Accrued expenses | 24,514 | 20,446 | ||
| 2022 usd financing warrants | 49,471 | 40,905 | ||
| Total current liabilities | 81,112 | 66,698 | ||
| Credit facility, long-term | 40,773 | 40,579 | ||
| Other non-current liabilities | 559 | 496 | ||
| Total liabilities | 122,444 | 107,773 | ||
| Additional paid-in capital | 937,795 | 913,914 | ||
| Accumulated other comprehensive income | 824 | 1,085 | ||
| Accumulated deficit | -659,770 | -582,672 | ||
| Total shareholders' equity | 278,849 | 332,327 | ||
| Total liabilities and shareholders' equity | 401,293 | 440,100 | ||